{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:17:25Z","timestamp":1790201845141,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"LEO Pharma A\/S, Denmark"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejogrb.2011.08.005","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T07:01:40Z","timestamp":1317020500000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile"],"prefix":"10.1016","volume":"159","author":[{"given":"Catherine","family":"Nelson-Piercy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Powrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yvonne","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2011.08.005_bib0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"6 Suppl.","key":"10.1016\/j.ejogrb.2011.08.005_bib0010","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"9713","key":"10.1016\/j.ejogrb.2011.08.005_bib0015","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(09)60996-X","article-title":"Pulmonary embolism in pregnancy","volume":"375","author":"Bourjeily","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0025","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMra0707993","article-title":"Venous thromboembolic disease and pregnancy","volume":"359","author":"Marik","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199204093261502","article-title":"Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis","volume":"326","author":"Hull","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199709043371002","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism","volume":"337","author":"Simonneau","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9378(03)00953-0","article-title":"Tinzaparin sodium for thrombosis treatment and prevention during pregnancy","volume":"190","author":"Smith","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0045","unstructured":"Centre for Maternal and Child Enquiries (CMACE) Perinatal Mortality 2009: United Kingdom. CMACE: London, 2011. Accessed: 18 April 2011. Available at: http:\/\/www.cemach.org.uk\/getattachment\/87faf695-b2cb-43d0-8eb8-9c2260789ee4\/Perinatal-Mortality-2009.aspx."},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06826.x","article-title":"The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey","volume":"139","author":"Voke","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2007.01622.x","article-title":"Antenatal pulmonary embolism: risk factors, management and outcomes","volume":"115","author":"Knight","year":"2008","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0060","first-page":"A50","article-title":"Treatment of established thrombosis in pregnancy with tinzaparin, a study of 32 patients for one centre","volume":"35","author":"Jindal","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/01443610802237080","article-title":"Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated?","volume":"28","author":"Byrd","year":"2008","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejogrb.2009.12.004","article-title":"Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes","volume":"149","author":"Sabadell","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","article-title":"Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies","volume":"77","author":"Hunt","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0080","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1160\/TH07-05-0329","article-title":"Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women","volume":"98","author":"Bauersachs","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203309353171","article-title":"Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity?","volume":"19","author":"Lefkou","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettila","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2011.08.005_bib0095","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511004970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511004970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:27:17Z","timestamp":1788877637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211511004970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0301211511004970"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.08.005","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}